IPP Bureau
Ginkgo Bioworks and Novo Nordisk to collaborate across R&D value chain
By IPP Bureau - April 11, 2024
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Evonik launches Botanicals & Natural Actives business segment
By IPP Bureau - April 11, 2024
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Syntegon showcases oral solid dosage portfolio at Achema
By IPP Bureau - April 11, 2024
Fluid bed processes: drying, granulating, and coating in just one product container
Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development
By IPP Bureau - April 11, 2024
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg
By IPP Bureau - April 10, 2024
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
NATCO Pharma receives warning letter from USFDA for facility in Kothur, Telangana
By IPP Bureau - April 10, 2024
The company will respond to the Warning Letter within the stipulated timelines
Lupin launches first generic version of Oracea in US
By IPP Bureau - April 10, 2024
Doxycycline Capsules, 40 mg is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Shivalik Rasayan’s API facility gets 7 observations from USFDA
By IPP Bureau - April 10, 2024
These observations are procedural in nature and will be responded within the stipulated time
President Murmu to inaugurate homeopathic symposium on World Homoeopathy Day 2024
By IPP Bureau - April 10, 2024
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
SPARC announces results from planned interim analysis of PROSEEK Study
By IPP Bureau - April 10, 2024
Eugia Steriles gets 3 observations from USFDA for injectable facility
By IPP Bureau - April 07, 2024
The observations are procedural in nature and will be responded to within the stipulated time
Bayer and Dr. Reddy's sign marketing and distribution agreement for second brand of Vericiguat in India
By IPP Bureau - April 07, 2024
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
By IPP Bureau - April 07, 2024
The Product is expected to be the first generic approval on the market
Pluss unveils Celsure XL VIP pallets
By IPP Bureau - April 07, 2024
A game changing solution for the pharmaceutical industry
Wacker and Pantherna intensify collaboration in the development and production of mRNA biopharmaceuticals
By IPP Bureau - April 07, 2024
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
